181 related articles for article (PubMed ID: 6225032)
21. Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.
Sparks DL; Hunsaker JC; Slevin JT; DeKosky ST; Kryscio RJ; Markesbery WR
Ann Neurol; 1992 Jun; 31(6):611-20. PubMed ID: 1355334
[TBL] [Abstract][Full Text] [Related]
22. Basal nucleus of Meynert. A neuropathological study in Alzheimer's disease, simple senile dementia, Pick's disease and Huntington's chorea.
Tagliavini F; Pilleri G
J Neurol Sci; 1983 Dec; 62(1-3):243-60. PubMed ID: 6230416
[TBL] [Abstract][Full Text] [Related]
23. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function.
Gibbs RB
Exp Neurol; 1998 Jun; 151(2):289-302. PubMed ID: 9628764
[TBL] [Abstract][Full Text] [Related]
24. [Abnormalities of neurotransmitters in Alzheimer's disease. Disturbance of the acetylcholine system and nucleus basalis of Meynert].
Arai H; Iizuka R
Nihon Rinsho; 1988 Jul; 46(7):1491-5. PubMed ID: 3221455
[No Abstract] [Full Text] [Related]
25. Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain.
McGeer PL; McGeer EG; Suzuki J; Dolman CE; Nagai T
Neurology; 1984 Jun; 34(6):741-5. PubMed ID: 6539435
[TBL] [Abstract][Full Text] [Related]
26. Calbindin-immunoreactive cholinergic neurones in the nucleus basalis of Meynert in Alzheimer-type dementia.
Ichimiya Y; Emson PC; Mountjoy CQ; Lawson DE; Iizuka R
Brain Res; 1989 Oct; 499(2):402-6. PubMed ID: 2804687
[TBL] [Abstract][Full Text] [Related]
27. Neuron loss in the nucleus basalis of Meynert in parkinsonism-dementia complex of Guam.
Nakano I; Hirano A
Ann Neurol; 1983 Jan; 13(1):87-91. PubMed ID: 6830170
[TBL] [Abstract][Full Text] [Related]
28. HDAC2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer's disease.
Mahady L; Nadeem M; Malek-Ahmadi M; Chen K; Perez SE; Mufson EJ
Neuropathol Appl Neurobiol; 2019 Jun; 45(4):380-397. PubMed ID: 30252960
[TBL] [Abstract][Full Text] [Related]
29. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.
Whitehouse PJ
Adv Neurol; 1987; 45():393-7. PubMed ID: 2881448
[No Abstract] [Full Text] [Related]
30. Neuropathological study on the nucleus basalis of Meynert in Pick's disease.
Mizukami K; Kosaka K
Acta Neuropathol; 1989; 78(1):52-6. PubMed ID: 2735190
[TBL] [Abstract][Full Text] [Related]
31. Loss of cholinergic pathways in vascular dementia of the Binswanger type.
Tomimoto H; Ohtani R; Shibata M; Nakamura N; Ihara M
Dement Geriatr Cogn Disord; 2005; 19(5-6):282-8. PubMed ID: 15785029
[TBL] [Abstract][Full Text] [Related]
32. Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases.
Greenamyre JT; Penney JB; Young AB; D'Amato CJ; Hicks SP; Shoulson I
Science; 1985 Mar; 227(4693):1496-9. PubMed ID: 2858129
[TBL] [Abstract][Full Text] [Related]
33. Senile plaques in Huntington's disease: a preliminary report.
Bruyn GW; Roos RA
Clin Neurol Neurosurg; 1990; 92(4):329-31. PubMed ID: 1963823
[TBL] [Abstract][Full Text] [Related]
34. Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease.
Arendt T; Bigl V; Tennstedt A; Arendt A
Neuroscience; 1985 Jan; 14(1):1-14. PubMed ID: 3974875
[TBL] [Abstract][Full Text] [Related]
35. Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type.
Quirion R; Martel JC; Robitaille Y; Etienne P; Wood P; Nair NP; Gauthier S
Can J Neurol Sci; 1986 Nov; 13(4 Suppl):503-10. PubMed ID: 2878714
[TBL] [Abstract][Full Text] [Related]
36. Neurotransmitters in dementia.
Nakamura S; Koshimura K; Kato T; Yamao S; Iijima S; Nagata H; Miyata S; Fujiyoshi K; Okamoto K; Suga H
Clin Ther; 1984; 7 Spec No():18-34. PubMed ID: 6152197
[TBL] [Abstract][Full Text] [Related]
37. The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type.
Wilcock GK; Esiri MM; Bowen DM; Hughes AO
J Neurol Neurosurg Psychiatry; 1988 Jun; 51(6):842-9. PubMed ID: 3404192
[TBL] [Abstract][Full Text] [Related]
38. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease.
Gilmor ML; Erickson JD; Varoqui H; Hersh LB; Bennett DA; Cochran EJ; Mufson EJ; Levey AI
J Comp Neurol; 1999 Sep; 411(4):693-704. PubMed ID: 10421878
[TBL] [Abstract][Full Text] [Related]
39. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya.
Mufson EJ; Jaffar S; Levey AI
J Comp Neurol; 1998 Mar; 392(3):313-29. PubMed ID: 9511920
[TBL] [Abstract][Full Text] [Related]
40. A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease.
Wood PL; Etienne P; Lal S; Nair NP; Finlayson MH; Gauthier S; Palo J; Haltia M; Paetau A; Bird ED
J Neurol Sci; 1983 Dec; 62(1-3):211-7. PubMed ID: 6142096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
